S&P 500
(0.12%) 5 303.27 points

Dow Jones
(0.34%) 40 004 points

Nasdaq
(-0.07%) 16 686 points

Oil
(-0.02%) $80.04

Gas
(1.60%) $2.67

Gold
(0.73%) $2 435.10

Silver
(3.67%) $32.41

Platinum
(0.98%) $1 100.70

USD/EUR
(-0.04%) $0.919

USD/NOK
(-0.06%) $10.67

USD/GBP
(0.01%) $0.787

USD/RUB
(0.09%) $91.05

Realtime updates for OncoTherapy Science, Inc. [4564.T]

Exchange: JPX Sector: Healthcare Industry: Biotechnology

Last Updated19 May 2024 @ 22:35

25% discount on Stockinvest.us - Use code: Podcast

20.00% ¥ 18.00

Live Chart Being Loaded With Signals

Commentary (19 May 2024 @ 22:35):

OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases...

Stats
Today's Volume	6.03M
Average Volume	2.61M
Market Cap	3.44B
EPS	¥0 ( 2024-05-09 )
Next earnings date	( ¥0 ) 2024-06-26
Last Dividend	¥0 ( N/A )
Next Dividend	¥0 ( N/A )
P/E	-3.13
ATR14	¥0.108 (0.57%)

Volume Correlation

Long: 0.07 (neutral)

Short: -0.42 (neutral)

Signal:(85.411) Neutral

OncoTherapy Science, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

OncoTherapy Science, Inc. Correlation - Currency/Commodity

-0.13
( neutral )

0.39
( neutral )

0.76
( moderate )

0.74
( moderate )

0.04
( neutral )

-0.58
( weak negative )

OncoTherapy Science, Inc. Financials

Annual	2023
Revenue:	¥610.12M
Gross Profit:	¥-177.72M (-29.13 %)
EPS:	¥-6.05

FY	2023
Revenue:	¥610.12M
Gross Profit:	¥-177.72M (-29.13 %)
EPS:	¥-6.05

FY	2022
Revenue:	¥1.13B
Gross Profit:	¥41.69M (3.67 %)
EPS:	¥-5.81

FY	2022
Revenue:	¥1.15B
Gross Profit:	¥113.91M (9.87 %)
EPS:	¥-13.72

Financial Reports:

No articles found.

OncoTherapy Science, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

OncoTherapy Science, Inc.

OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases. The company's clinical development product pipeline also comprise cancer- specific peptide vaccines, including S-588410, which is in Phase III clinical trials for the treatment esophageal cancer, as well as in Phase II clinical trials for the treatment of bladder cancer; S-488210 that is in Phase I/II clinical trials for the treatment of head and neck cancer; and S-588210, which is in Phase I clinical trials for the treatment of solid tumor. In addition, it is developing antibody drugs consisting of OTSA101, which is in Phase I clinical trials for synovial sarcoma; and KHK6640, an anti-amyloid beta peptide antibody that is Phase I clinical trials for Alzheimer's disease. Further, the company provides contract analysis services. OncoTherapy Science, Inc. was founded in 2001 and is headquartered in Kawasaki, Japan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.